Publisher's Synopsis
A gene called MTHFR is in charge of producing the methylenetetrahydrofolate (MTHFR) enzyme.
For the body to transform the amino acids methionine and homocysteine into their more vital forms, this enzyme is crucial.
Numerous health issues, most notably an elevated risk of birth abnormalities and neuropsychiatric disorders, can result from mutations in the MTHFR gene.
Anyone with one of these mutations is more likely to experience methylation-related issues, such as an increased risk of cancer, mental disorders, and birth defects. About 60% of all MTHFR mutations are caused by the most frequent MTHFR mutation, the C677T mutation.
People with the MTHFR C677T mutation are more likely to experience methylation-related issues, including an increased risk of cancer, mental disorders, and birth abnormalities. The second most frequent MTHFR mutation, the A1298C mutation, is responsible for 10% of all MTHFR mutations.
People with the MTHFR A1298C mutation are more likely to experience methylation-related issues, including an increased risk of cancer, mental disorders, and birth abnormalities. The MTHFR A66G mutation, which accounts for 1% of all MTHFR mutations, is the least frequent MTHFR mutation.
People with the MTHFR A66G mutation are more likely to experience methylation-related issues, including an increased risk of cancer, mental disorders, and birth abnormalities.
